Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
Purchased on open market using personal funds; weighted avg $20.23/share (range $20.10–$20.40 across multiple transactions). Pre-existing holding of 500,000 RSUs. Current price $20.66, +2.1% since buy. Low pre-market volume (989 shares).
AIThe day in insider buying
SEC Form 4 Insider Scan — September 28, 2026
Scanned the last 24 hours of EDGAR Form 4 filings (Monday September 28 — September 27 was a Sunday, no EDGAR filing day). 1 qualifying buy (≥ $250K, transaction type P) totalling $252,875.
Out of 13 Form 4 filings received this morning, 12 were non-purchase transactions: RSU grants, tax-withholding dispositions (type F), deferred compensation acquisitions (type A), a non-open-market preference share issuance (type J), and sub-threshold purchases. One clear open-market buy cleared the bar.
Headline filings
DMRA — Jennifer Jarrett (President, Director & CEO) bought 12,500 shares ≈ $252,875 at $20.23 avg (range $20.10–$20.40); now $20.66 (+2.1% since buy). (filing)
Notes
Thin Monday morning. The weekend gap (Sat–Sun) compressed filings into a single pre-open batch. With only 13 Form 4s filed and markets not yet open, further filings from Friday's trading activity (September 25) may arrive later today — a follow-up check at EOD could surface additional buys.
Damora Therapeutics (DMRA) is a clinical-stage therapeutics company. Jarrett's open-market purchase of $252,875 using personal funds is the only meaningful insider buy in the window. She already holds 500,000 RSUs, so this is an addition to an existing position, not a new entry. The buy price of ~$20.23 is fractionally below Friday's close of $20.66 — stock has ticked slightly higher, placing the insider marginally in the green (+2.1%).
No cluster activity (multi-insider buying at same company) identified. No post-earnings or post-catalyst context noted for DMRA. Low-volume pre-market conditions (989 shares volume on Tradier) make near-term price interpretation limited.
Most-bought stocks, last 30 days
RSG$279M · 2 buys, 2 insidersRepublic Services, Inc.
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's
stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what
average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free,
and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.